Operations Biotechnology February 2015

Integral service around a transaction
BY : Diego GutiérrezMarch Tue, 2015
February 2015 has been an active month for the Biotech sector. Spanish venture capital has carried out large deals in both Spanish and foreign companies. In addition, there have also been M&A activities in the sector.


Cloud- Europe - investment analysis - up to 2014 corrected

Risk capital operations

Ysios capital leads a $8.7M investment in Prexton Therapeuticsa Swiss company that is developing a treatment for the motor complications associated with Parkinson's disease. In addition to Ysios, Sunstone Capital has also led the round.

"The participation in Prexton Therauphethics is the first investment of its Ysios Biofund II fund, which in March made its second investment by entering into a new equity investment in Prexton Therauphethics. Aura BiosciencesThe company is developing an innovative therapy for the treatment of ocular melanoma," says Diego Gutiérrez of Abra-Invest.

Iden Biotechfounded in 2005 by the Carbohydrate Metabolism research group of the Institute of Agrobiotechnology of Navarra, has received a €4M round in which the following have taken part Sodena  and CRB inverbio. Iden Biotech identifies plant genes of agronomic value for crop improvement and develops products of biological origin to improve crop quality.

The aim of the round is to expand its research equipment and facilities in Navarra, as well as to advance several of its breeding and agrobiological development programmes.

Mergers and Acquisitions in biotechnology

NMC Health buy the Eugin Clinic in Barcelona, the leading in vitro fertilisation centre in Spain, to
for €143M. The sellers, in addition to ProA Capital, include some of Eugin's founders and management.

Vita 34, Europe's first private cord blood bank, has acquired the Spanish company Secuvita.

"Vita 34 had already bought the majority stake in Secuvita 4 years ago and now with the full acquisition of the company, Vita 34 implements its commercial strategy in Secuvita," says Diego Gutiérrez.

In March, Vita 34 continued to be active in acquisitions, acquiring the assets of Vivocell, Austria's largest private stem cell bank.

Soria Naturalthe leading company in the manufacture and sale of natural products, phytotherapy and organic food, has completed the purchase of the Madrid laboratory Homeolab. This acquisition, which began in August 2014, will allow them to expand their product catalogue to become a benchmark in the homeopathy market in Spain.


The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?